Myconeos Limited, established in 2018, is a pioneering entity in the field of fungal biotechnology. The company operates from the United Kingdom with a mission centered on “Fungal research at the heart of innovation.” By harnessing the exploratory potential of fungi, Myconeos has successfully engineered new fungal strains for various applications such as food production, bio-remediation, and bio-fermentation. Their notable breakthrough lies in the identification of the sexual mating cycle for Penicillium roqueforti, breathing new life into the stagnant blue cheese market.
With the launch of their proprietary Mycoforti® cultures, Myconeos is set to transform cheese production, marking the UK’s first-ever production of blue cheese starter cultures. This innovation positions the company as a worldwide leader in this niche market. Recently, Myconeos secured a £436.00K Seed Round investment from PeakBridge in November 2022, fueling its future research pipeline and market expansion strategies. Investors should consider Myconeos a valuable opportunity due to its cutting-edge research and market-first product offerings.